Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 14 (FTH1P14) is a processed pseudogene derived from the FTH1 gene, which encodes the heavy subunit of ferritin, the major intracellular iron storage protein. Unlike the canonical ferritin genes, FTH1P14 does not code for a functional protein. While ferritin pseudogenes were historically regarded as nonfunctional genomic elements, recent research suggests some pseudogenes (including other FTH1 family members) may regulate gene expression post-transcriptionally, often by acting as molecular decoys for microRNAs or as sources of non-coding RNAs. However, there is no evidence that FTH1P14 serves as a protein or direct therapeutic target, nor is it involved in classical receptor, enzyme, transporter, or transcription factor activity[3][4][6]. FTH1P14 is classified as a processed pseudogene, meaning it is a DNA sequence similar to the FTH1 gene but does not encode a functional heavy chain ferritin protein[3][4][6]. Unlike FTH1 itself, whose protein is relevant for iron storage and implicated in neurodegenerative and metabolic disease, FTH1P14 lacks evidence for a protein product or direct functional role in cell biology or disease, aside from possible regulatory roles at the RNA level[3][4]. Other FTH1 pseudogenes (such as FTH1P11 and FTH1P16) have shown some capacity to modulate gene expression in cancer cell models, suggesting the general family can have non-coding RNA functions; specific evidence for FTH1P14 acting this way remains unestablished[4]. FTH1P14 is a pseudogene derived from ferritin heavy chain 1, does not encode a protein or serve as a therapeutic target, and is primarily relevant as a genomic element with emerging, but as yet unproven, potential for non-coding regulatory functions[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 14 (FTH1P14).